Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycamine vs Itraconazole for Fungal Prophylaxis in HSCT
NCT00794703Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of micafungin in invasive fungal infection (IFI), sponsored by Astellas Pharma. Started Nov 2008; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00794703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794703.